Smart pump trial aims to ease diabetes management for kids

NCT ID NCT05908708

Recruiting now Disease control Sponsor: Sheba Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 120 Israeli children and teens with type 1 diabetes who use the Medtronic 780G system, a closed-loop insulin pump that automatically adjusts insulin. Researchers will track blood sugar control, sleep, diet, and emotional well-being over two years. The goal is to see if this technology improves glucose levels and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Medtronic 780G hybrid closed-loop system (insulin pump with continuous glucose monitor)
What this could lead to: If successful, this could show that the 780G system helps children with type 1 diabetes maintain better blood sugar levels and improve daily life.
What could go wrong: This is an observational study, not a controlled trial, so results may be less definitive. The device is already approved, so the main question is how well it works in real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILD, ONLY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

CHILD syndrome type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHILD, ONLY TYPE 1 DIABETES

Contacts and locations

Locations

Sheba Medical Center
RECRUITING

Ramat Gan, Please Select, 5265601, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.